Steven Kanner, Ph.D.

Steven Kanner, Ph.D.

Chief scientific officeratCaribou Biosciences· In proxies 2023–2024

Pay in FY2024+32% from the year before · Caribou Biosciences stock -72.3% the same year

Steven Kanner, Ph.D. was paid $1.6M in FY2024 (Dec), up 32%. Caribou Biosciences stock fell 72.3% that year.

Pay$100 in the stock at the end of FY22 → $25
Pay is from the Summary Compensation Table of each Caribou Biosciences proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Caribou BiosciencesPublic company · 3 yr
    • Chief scientific officer2023 – Present · 3 yrStock in role -91%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?